A comparative study of the dose-response and time course of action of rocuronium and vecuronium in anesthetized adult patients

Journal of Clinical Anesthesia

Volumn 10, Issue 5, 1998, Pages 410-415

  Xue, Fu S ^a   Liao, Xu ^a   Liu, Jian H ^a   Tong, Si Y ^a   Zhang, Yan M ^a   Zhang, Ru J ^a   An, Gang ^a   Luo, Lai K ^a  

^a PLASTIC SURGERY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; FENTANYL; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OXYGEN; ROCURONIUM; THIOPENTAL; VECURONIUM; ANDROSTANE DERIVATIVE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; FEMALE; GENERAL ANESTHESIA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; ANESTHETIC RECOVERY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; TIME; ULNAR NERVE;

ADOLESCENT; ADULT; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; FENTANYL; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE; OXYGEN; PROSPECTIVE STUDIES; THIOPENTAL; TIME FACTORS; ULNAR NERVE; VECURONIUM BROMIDE;

EID: 0032129265     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(98)00056-7     Document Type: Article

References (31)

1. Muir AW, Marshall RJ: Comparative neuromuscular blocking effects of vecuronium, pancuronium, Org 6368 and suxamethonium in the anaesthetized domestic pig. Br J Anaesth 1987;59: 622-9.
2. Bowman WC, Rodger IW, Houston J, Marshall RJ, Mclndewar I: Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988;69:57-62.
3. Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG: Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989;63:400-10.
4. Muir AW, Anderson K, Marshall RJ, et al: The effects of a 16-N-homopiperidino analogue of vecuronium on neuromuscular transmission in anaesthetized cats, pigs, dogs, and monkeys, and in isolated preparations. Acta Anaesthesiol Scand 1991;35:85-90.
5. Schwartz AE, Matteo RS, Ornstein E, Halevy JD, Diaz J: Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg 1992;74:515-8.
6. Donlon JV: A new approach to the study of four nondepolarizing relaxants in man. Anesth Analg 1974;53:934-9.
7. Waud BE, Waud DR: On dose-response curves and anesthetics. Anesthesiology 1970;33:1-4.
8. Mellinghoff H, Diefenbach, Bischoff A, Grond S, Buzello W: Dose-response relationship of rocuronium bromide during intravenous anaesthesia. Eur J Anaesthesiol 1994;11(suppl 9):20-4.
9. Viby-Mogensen J: Dose-response relationship and time course of action of rocuronium bromide in perspective. Eur J Anaesthesiol 1994;11(suppl.9):28-32.
10. Booth MG, Marsh B, Bryden FM, Robertson EN, Baird WL: A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992;47:832-4.
11. Miller RD, von Ehrenburg W. The contribution of muscle relaxants to the advancement of anaesthetic practice: what is required of new compounds? Eur J Anaesthesiol 1994;11(Suppl.9): 1-8.
12. Agoston S, Vandenbrom RH, Wierda JM: Clinical pharmacokinetics of neuromuscular blocking drugs. Clin Pharmacokinet 1992; 22:94-115.
13. Gibson FM, Mirakhur RK, Clarke RS, Lavery GG: Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. Br J Anaesth 1985;57:1060-2.
14. Smith CE, Donati F, Bevan DR: Cumulative dose-response with infusion: a technique to determine neuromuscular blocking potency of atracurium and vecuronium. Clin Pharmacol Ther 1988;44:56-64.
15. Fisher DM, Fahey MR, Cronnelly R, Miller RD: Potency determination for vecuronium (Org NC45): comparison of cumulative and single-dose techniques. Anesthesiology 1982;57:309-10.
16. Katz RL, Stirt J, Murray AL, Lee C: Neuromuscular effects of atracurium in man. Anesth Analg 1982;61:730-4.
17. Donlon JV Jr, Savarese JJ, Ali HH, Teplick RS: Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. Anesthesiology 1980; 53:161-6.
18. Gramstad L, Lilleaasen P: Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration. Br J Anaesth 1985;57:1052-9.
19. Krieg N, Crul JF, Booij LH: Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man. Br J Anaesth 1980;52:783-8.
20. Vanlinthout LE, Booij LH, van Egmond J, Robertson EN: Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium. Br J Anaesth 1996;76:389-95.
21. Xue FS, Liao X, Tong SY, Liu JH, An G, Luo LK: Dose-response and time-course of effect of rocuronium in male and female anesthetized patients. Anesth Analg 1997;85:667-71.
22. Robertson EN, Booij LH, Fragen RJ, Crul JF: Clinical comparison of atracurium and vecuronium (ORG NC 45). Br J Anaesth 1983;55:125-9.
23. Gramstad L, Lilleaasen P: Dose-response relation for atracuronium, ORG NC 45 and pancuronium. Br J Anaesth 1982;54:647-51.
24. Khalil M, D'Honneur G, Duvaldestin P, Slavov V, De Hys C, Gomeni R: Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994;80: 1241-7.
25. Cooper AR, Wierda JMKK, Mirakhur RK, Maddineni VR. Pharmacokinetics of rocuronium bromide in patients with and without renal failure. Eur J Anaesthesiol 1995;11(suppl 9):43-4.
26. Morita T, Tsukagoshi H, Sugaya T, Yoshikawa D, Fujita T: The effects of sevoflurane are similar to those of isoflurane on the neuromuscular block produced by vecuronium. Br J Anaesth 1994;72:465-7.
27. Wierda JM, Proost JH, Schiere S, Hommes FD: Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans. Eur J Anaesthesiol 1994;11 (suppl 9): 66-74.
28. Loo JCK, Riegelman S: Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. J Pharm Sci 1970;59:53-5.
29. Sparr HJ, Khuenl-Brady KS, Eriksson LI: Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia. Eur J Anaesthesiol 1994;11:(Suppl 9):63-5.
30. Cooper RA, Mirakhur RK, Maddineni VR: Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia. Anaesthesia 1993;48:103-5.
31. McCarthy G, Elliott MP, Mirakhur RK, Cooper R, Sharpe TD, Clarke RS: Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesthesiol Scand 1992;36: 383-6.